400-1022-688

News

News
Location:Home >News >News

April 24, 2014, Lumigenex announced today

Poptime:2014-10-19 Page View:2110

April 24, 2014, Lumigenex announced today that it had received certificates of registration from CFDA for four POCT immunoassay kits: Creatine Kinase (CK-MB) quantitative detection kit (time-resolved fluorescence immunochromatographic assay); Myoglobin (MYO) quantitative detection kit ((time-resolved fluorescence immunochromatographic assay); cardiac troponin I (cTnI) quantitative detection kit ((time-resolved fluorescence immunochromatographic assay); N-terminal brain natriuretic peptide (NT-proBNP) quantitative detection kit ((time-resolved fluorescence immunochromatographic assay).
Earlier
Mar. 2014

CFDA approvals for five immunoassay reagents adaptable to most chemical analyzers were obtained

Feb. 2014

CFDA approvals for time-resolved fluorescence immunochromatographic analyzer were obtained

Sep. 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment